Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rescuing the Function of Missense-Mutated Tumor Suppressor <i>VHL</i> using Stabilizing Small Molecules.

bioRxiv : the preprint server for biology·2026
Same author

Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosis.

Molecular cancer research : MCR·2026
Same author

PPIscreenML is a method for structure-based screening of protein-protein interactions using AlphaFold.

eLife·2026
Same author

Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosis.

bioRxiv : the preprint server for biology·2025
Same author

Oligomerization of protein arginine methyltransferase 1 and its effect on methyltransferase activity and substrate specificity.

Protein science : a publication of the Protein Society·2024
Same author

Musashi-2 (MSI2) regulation of DNA damage response in lung cancer.

Research square·2024
Same journal

RETRACTED: Kim et al. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Regulating the Visceral Adipose-Tissue Function. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 846.

International journal of molecular sciences·2026
Same journal

Correction: Mahmud et al. Thymoquinone Attenuates NF-κβ Signalling Activation in Retinal Pigment Epithelium Cells Under AMD-Mimicking Conditions. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 11473.

International journal of molecular sciences·2026
Same journal

Correction: Borovikov et al. The Twisting and Untwisting of Actin and Tropomyosin Filaments Are Involved in the Molecular Mechanisms of Muscle Contraction, and Their Disruption Can Result in Muscle Disorders. <i>Int. J. Mol. Sci</i>. 2025, <i>26</i>, 6705.

International journal of molecular sciences·2026
Same journal

Correction: Molagoda et al. Flavonoid Glycosides from <i>Ziziphus jujuba</i> var. <i>inermis</i> (Bunge) Rehder Seeds Inhibit α-Melanocyte-Stimulating Hormone-Mediated Melanogenesis. <i>Int. J. Mol. Sci.</i> 2021, <i>22</i>, 7701.

International journal of molecular sciences·2026
Same journal

Correction: Guo et al. Integrated Transcriptomic and Metabolomic Analysis Reveals the Molecular Regulatory Mechanism of Flavonoid Biosynthesis in Maize Roots Under Lead Stress. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 6050.

International journal of molecular sciences·2026
Same journal

Correction: Chang et al. Improvement of Carbon Tetrachloride-Induced Acute Hepatic Failure by Transplantation of Induced Pluripotent Stem Cells Without Reprogramming Factor c-Myc. <i>Int. J. Mol. Sci.</i> 2012, <i>13</i>, 3598-3617.

International journal of molecular sciences·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2026

Open-source Single-particle Analysis for Super-resolution Microscopy with VirusMapper
07:38

Open-source Single-particle Analysis for Super-resolution Microscopy with VirusMapper

Published on: April 9, 2017

10.0K

vScreenML v2.0: Improved Machine Learning Classification for Reducing False Positives in Structure-Based Virtual

Grigorii V Andrianov1,2, Emeline Haroldsen1, John Karanicolas1,3

  • 1Cancer Signaling & Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

International Journal of Molecular Sciences
|November 27, 2024
PubMed
Summary
This summary is machine-generated.

vScreenML 2.0 enhances virtual screening by improving hit-finding rates. This new Python tool offers better usability and accuracy than previous versions and other methods for drug discovery.

Keywords:
drug discoverymachine learningvirtual screening

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.1K

Related Experiment Videos

Last Updated: Jun 7, 2026

Open-source Single-particle Analysis for Super-resolution Microscopy with VirusMapper
07:38

Open-source Single-particle Analysis for Super-resolution Microscopy with VirusMapper

Published on: April 9, 2017

10.0K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.4K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.1K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Machine learning

Background:

  • Traditional virtual screening methods often yield low hit rates, with many predicted compounds failing to interact with target proteins.
  • Make-on-demand chemical libraries are increasingly used, necessitating more accurate virtual screening tools.
  • Previous machine learning tools like vScreenML showed promise but suffered from usability issues and software dependencies.

Purpose of the Study:

  • To introduce vScreenML 2.0, a significantly improved version of the vScreenML virtual screening tool.
  • To address the limitations of the original vScreenML, focusing on enhanced usability and streamlined implementation.
  • To provide a more effective computational method for identifying potential drug candidates.

Main Methods:

  • Development of vScreenML 2.0 as a streamlined Python implementation.
  • Comparative benchmarking against other widely used virtual screening tools.
  • Evaluation of hit-finding discovery rates and accuracy.

Main Results:

  • vScreenML 2.0 demonstrates superior performance in virtual screening hit discovery compared to existing tools.
  • The new implementation offers improved usability and removes dependencies on obsolete or proprietary software.
  • Benchmarks confirm enhanced accuracy in identifying compounds likely to engage target proteins.

Conclusions:

  • vScreenML 2.0 represents a significant advancement in computational drug discovery, offering improved hit-finding efficiency.
  • The tool's enhanced usability and Python-based implementation facilitate broader adoption in virtual screening workflows.
  • vScreenML 2.0 provides a more reliable and accessible method for accelerating the identification of novel therapeutic agents.